Journal article
Clinical trial: factors associated with freedom from relapse of heartburn in patients with healed reflux oesophagitis ‐ results from the maintenance phase of the EXPO study
Abstract
BACKGROUND: Ability to predict freedom from heartburn relapse during maintenance therapy for healed reflux oesophagitis may facilitate optimal treatment choices for individual patients.
AIM: To determine factors predicting freedom from heartburn relapse during maintenance proton pump inhibitor therapy in patients with healed reflux oesophagitis.
Authors
LABENZ J; ARMSTRONG D; ZETTERSTRAND S; EKLUND S; LEODOLTER A
Journal
Alimentary Pharmacology & Therapeutics, Vol. 29, No. 11, pp. 1165–1171
Publisher
Wiley
Publication Date
June 2009
DOI
10.1111/j.1365-2036.2009.03990.x
ISSN
0269-2813
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
2-PyridinylmethylsulfinylbenzimidazolesAdultAgedAged, 80 and overAnti-Ulcer AgentsDose-Response Relationship, DrugDouble-Blind MethodEsomeprazoleEsophagitis, PepticFemaleHeartburnHumansMaleMiddle AgedPantoprazoleProton Pump InhibitorsRegression AnalysisSecondary PreventionTime FactorsTreatment OutcomeYoung Adult